19736 S0214 M1 1571

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

3

Document text

BioNTech SE 02/15/2021
An der Goldgrube 12
Mainz Rhineland-Palatinate
Germany 55131215-280-5503
COVID-19 Vaccine (BNT162, PF-07302048) 019736
Prophylactic immunization against COVID-19 in adults 
16 years of age
0 2 1 3
Summary Monthly Safety Report (SMSR)
3
FDA-CBER-2021 5683-1079254
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE 
Elisa Harkins, Global Regulatory Lead, Pfizer Global Regulatory Affairs - Vaccines
215-280-5503 (845) 474-3500 
500 Arcola Road
 
Collegeville PA
United States of America [email protected] 
02/15/2021
United States of America
3
(b) (6)
FDA-CBER-2021-5683-1079255
3
FDA-CBER-2021-5683-1079256